Clonal ZEB1-driven mesenchymal transition promotes targetable oncologic anti-angiogenic therapy resistance.
10.1158/0008-5472.CAN-19-1305 Chandra et al. Cancer Res.
Chandra A, Jahangiri A, Chen W, Nguyen AT, Yagnik G, Pereira MP, Jain S, Garcia JH, Shah SS, Wadhwa H, Joshi RS, Weiss J, Wolf KJ, Lin JG, Müller S, Rick JW, Diaz AA, Gilbert LA, Kumar S, Aghi MK
Study details